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SUMMARY
In order to assess whether an autonomic change accom-
panies desensitization by reciprocal inhibition we exposed
two groups of anxious subjects to a stressful situation.
One group was 'relaxed' pharmacologically using methoxy-
flurane. The 'relaxed' group was desensitized to the stress
but showed no difference in autonomic responses. We
have concluded that reciprocal inhibition acts at a cognitive
and affective level, rather than as a purely autonomic
change.
S. Air. Med. l., 45, 781 (1971).
The emotion of fear, or anxiety, may be diminished by a
technique now commonly referred to as 'desensitization by
reciprocal inhibition"" and this, in turn, is efficacious in
bringing about an improvement in general adjustment and
performance.'" It has been shown that relaxation is an
essential feature of the desensitization process.'
A conceptual problem remains concerning the level at
which relaxation has its effect. Wolpe, in an early state-
ment on the rationale of therapy by reciprocal inhibition,
says: 'If a response antagonistic to anxiety can be made
to occur in the presence of anxiety evoking stimuli so that
it is accompanied. by a complete or partial suppression of
the anxiety responses, the bond between these stimuli and
the anxiety responses will be weakened': The exact nature
of the alleged 'antagonism' is, however, not clear. The
orthodox Wolpe model seems to assume that the muscular
relaxations oust the anxiety responses directly and on the
physiological level. Thus, the beneficial effects of muscular
relaxation may be due to 'the effort of relaxing skeletal
muscles, which carries with it autonomic responses oppo-
site in direction to those characteristic of aIL'{iety'.' Yet
clearly there is no logical or physiological necessity in this
association. '
If relaxation is to work on the autonomic nervous sys-
tem then it follows that: (i) the induction of relaxation
must manifest itself by a reduction in the autonomic indi-
ces of anxiety; and (ii) 'if any permanent lessening of anx-
iety occurs, i.e. has been learned, it should manifest itself
by an equally permanent change in the physiological indi-
ces on the presentation of the same stimulus.
Work with a bearing on physiological changes during
the therapy of anxiety has been relatively little reported'"
Friedman and Silverstone'O used intravenous methohexi-
tone sodium (Brietal) to induce muscle relaxation directly,
without the need for special training sessions, and found
that desensitization was facilitated. Lader and Wing,' have
found a supranormal response to auditory stimuli in
anxious patients, as shown in certain physiological indices
'Date received: 22 April 1971.
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of anxiety, viz. heart rate and spontaneous fluctuations
and habituation of galvanic skin response.
We decided to combine these approaches, namely to
induce relaxation by pharmacological means and to exa-
mine the effects of this on the state of anxiety itself as
experienced psychologically and manifested autonomically.
METHOD
Induction of Relaxation
The drug chosen to induce a feeling of relaxation was
methoxyflurane (Penthrane). The drug was used to induce
a feeling of relaxation and not the physiological effects
brought about by the greater dosage used for anaesthesia."
The drug was administered by the special apparatus sup-
plied (Analgizer), Subjects were instructed to breathe from
it until they felt relaxed. They then stopped inhaling. and
repeated the process to maintain the relaxed state.
Subjects
Ten subjects were drawn from Tara Hospital, where
they were undergoing treatment for disorders in which
anxiety had been diagnosed as playing a major part. They
were all females, aged 19 - 52 years.
Table I includes the medication received by each sub-
ject at Tara. Subjects, matched for age and similarity of
clinical features, were assigned to the 2 groups. Subjects
were selected by the medical staff who were unaware of
the exact nature of the experiment.
Psychological Tests
1. On admission to Tara Hospital, diagnosis on a clini-
cal basis showed a marked element of anxiety in each
case (Table I).
2. Cattell's IPAT instrument was administered to each
subject before the start of the first experimental session.
3. On entry into the test room, each subject was sepa-
rately evaluated by each of us, on a 4-point scale, for out-
ward manifestation of anxiety.
4. After each day's testing, subjects were asked to report
on stress experienced under the various conditions of the
experiment (see under 'Test Procedure', 7 and 10).
Physiological Measurements
The measurements were recorded on paper on an Either
polygraph. Heart rate was monitored by means of stan-
dard electrocardiogram lead I; galvanic skin response was
measured by recording the skin potential from the index
finger of the left hand and the integrated electromyogram
strapped from the left trapezius muscle of the neck. The
electro-encephalogram was recorded from the C4 - 02
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Neurotic depression with anxiety
Obsessionaf state with anxiety
Personality disorder with anxiety
Neurotic depression with anxiety
Anxiety state with depression
Endoreactive depression with anxiety
Drug therapy
Trasicor 20 mg t.d.s.
Amitryptyline 10 mg t.d.s.
Mellerif 100 mg nocte
Mandrax 1 tablet nocte
Nardil 15 mg b.d.
Parnate 10 mg td.
Librium 5 mg t.d.s.
Pertofran 25 mg q.i.d.
Mellerif 200 mg nocte
Tofranil 50 mg t.d.s.
Valium 2 mg t.d.s.
With methoxyflurane
7 22 Personality disorder with anxiety
8 40 Neurotic depression with anxiety
9 29 Manic-depressive psychosis with anxiety
10 29 Anxiety state with reactive depression
Oxazepam 15 mg t.d.s.
Trasicor 10 mg t.d.s.
Parnate 10 mg b.d.
Vafium 5 mg t.d.s.
Mandrax 1 tablet nocte
Parnate 10 mg b.d.
Valium 10 mg t.d.s.
locations (international 10 - 20 system). This last para-
meter was also recorded on magnetic tape.
Stimulation Procedure
This was by means of a buzzer, sounded for 1 second
at random intervals but within a range of 4 - 14 seconds
of each other. There were a total of 30 presentations in
each sequence. The buzzer sound was a 100 Hz square
wave from a loudspeaker mounted on a wall 2 m from
the subject's head and which had an intensity of 87 db
(ret. 0.00002 dynes per sq cm) at the subject's ear.
Test Procedure
The subjects were told that they were to be exposed to
auditory stimuli, and that they would be asked to inhale
a completely safe relaxing substance. The voluntary na-
ture of the experiment was emphasized. The IPAT test
was then administered. The subjects were then connected
to the polygraph in the test room. The following procedure
was then carried out:
1. All parameters were recorded for a total of 2 minutes,
to provide basal readings, no stimulation being given (RI).
2. With no warning, the buzzer stimulation programme
began, and all parameters were measured throughout the
period (NI).
3. Immediately on completion of this sequence the same
one of us entered the test room and repeated the instruc-
tions concerning the use of the Analgizer, whicll was then
handed to the subject. The experimenter then left the
room. According to a pre-arranged random schedule half
the subjects were given the Analgizer charged with a
measured amount of methoxyflurane and half were handed
the instrument empty.
4. A period of 2 minutes now ensued when the subject
breathed from the 'Analgizer' (R2).
5. The buzzer programme was then repeated (N2).
6. The Analgizer was then removed and weighed.
7. The subject was released from the test room, asked
how the stress experienced under N2 compared with that
under NI, and thanked.
8. On the following day at the same time the subjects
returned and recordings at rest were taken for 2 minutes
(R3).
9. The buzzer stimulation programme was repeated (N3).
10. The subjects were released and questioned concern-
ing stress experienced in comparison with the previous day.
RESULTS
The Effectiveness of the Stimulation
All subjects reported that the stimulation procedure was
highly arousing with unpleasant affect. One patient was
unable to proceed once the buzzer had sounded a few times,
and was released from the experiment and replaced.
The Effectiveness of the Methoxyflurane
AJI subjects who had the drug reported feeling increas-
ingly relaxed during its use, whereas the others reported
no change while using the Analgizer. The weight difference
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TABLE 11. PSYCHOLOGICAL MEASUREMENTS
Report by subject of stress
experienced'
Overt anxiety
Subject IPAT totalled N2 vs. Nl N3 vs. prior
1
1 10 4 0 0
2 9 6 0 0
3 10 7 0 +
4 9 3 0 0
5 10 4 0 0
1
6 9 3 + +
7 10 6 + +
8 10 2 + +
9 9 4 + +
10 10 5 + +
• 0 indicates that the subject reported feeling no better.
+ indicates that the subject reported feeling better.
Psychological Measurements
Clinical diagnosis on admission to Tara Hospital showed
marked Jements of anxiety in all cases (Table I).
The IPAT scores, on a scale from 0 - 10 standard sten
score, and our own assessments of overt anxiety, are set
out in Table ll. There is no significant difference in anxiety
levels in terms of these two scores between the two groups.
The range of values in our observations ()f overt anxiety
manifested by the subjects is greater than that shown by
the IPAT results in which both ove~t and covert anxiety
is assessed.
Table II also shows that subjects in the 'with methoxy-
flurane' group, in their subjective assessment, without ex-
ception, found the N2 situation to be less stressful than
N I. and N3 again less so than the previous day. On the
other hand, no subjects in the 'without methoxyflurane·
group found N2 less stressful than NI, and only one
found N3 preferable to the previous day. These differences
were significant at a level of P < 0·0 I for NZ \"S. I and
P < 0·05 for 31's. the previous day.
Physiological Measurements (Table DJ)
I. Heart rate. The average and the peak heart rates" were
calculated for each stage in the experimental procedure.
The two groups did not differ significantly during RI.
In order to compare each subjecrs heart rate during 2
?
TABLE Ill. PHYSIOLOGICAL MEASUREMENTS
Rl Nl N2 R3 N3
Subject HR SF EMG HR GSR EMG HR GSR EMG HR SF EMG HR GSR EMG
P A P A P A P A P A
1 72 70 0 1 86 73 12 4 82 73 3 3 75 71 0 3 75 71 0 10
2 120 102 1 55 113 95 2 31 113 93 0 27 120 105 4 65 120 93 3 45
W;>ho", 1 3 90 86 0 16 95 85 15 26 90 86 22 35 82 86 0 60 90 86 1 43
methoxyflurane
4 82 75 0 10 79 76 0 3 82 78 0 0 82 79 0 16 82 74 0 20
5 82 76 1 28 82 77 0 52 86 77 1 40 90 82 0 36 90 77 0 29
6 100 88 0 3 100 86 2 5 100 90 0 1 100 91 0 8 106 94 3 16
7 79 75 0 26 82 79 14 25 90 75 4 26 69 69 0 22 75 71 3 19
With 1 8 79 72 0 18 74 69 1 10 86 82 1 9 79 70 2 12 82 73 0 25methoxyflurane
9 90 74 13 1 90 74 18 3 90 75 12 4 90 74 2 9 100 7-1 8 8
10 121 110 7 3 121 110 9 2 113 105 0 1 121 121 10 2 121 114 10 2
HR=heart rate. GSR=total number of galvanic skin responses.
P=peak heart rate. EMG=value of integrated electromyogram (see text).
A=average heart rate. SF=spontaneous fluctuations of galvanic skin responses.
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HR (N 1) - HR (N2)
with that during NI, was calculated,
HR (NI)
HR (N 1) - HR (N3)
and for comparison of N3 and NI
HR (NI)
conditions. Neither of these measurements showed a sig-
nificant difference between the 'drug' and 'no-drug' groups.
2. Galvanic skin response. This was measured as skin
potential changes; only changes of 10 fLY, or over, were
counted.
Spontaneous fluctuations during RI, and individual
changes in the total number of responses during NI, N2
and N3 were·compared as above for heart rate. None of
these measures significantly separated the two groups.
3. Electromyogram. The integrated electromyogram trace
was scored by measuring the height of the record above
the base line at 85 identical intervals during the stimulation
procedure.
There was no significant difference between the groups
during RI, nor during NI, N2 and N3.
A progressive reduction in heart rate, galvanic skin re-
sponse and electromyogram trace was noted in some
members of both groups across the experiment. This may
be ascribed to the effect of repetition/ habituation.
4. Electro-encephalogram. The a-index and evoked re-
sponses will be reported upon separately.
DISCUSSION
The precise amount of drug inhaled by each subject has not
been taken into account. Subjects were instructed to inhale
until a sense of pleasant relaxation was achieved. This they
were able to attain within a narrow dose range, and the
exact amount consumed to achieve this state is of little
further significance. _
We are aware that among the medication being received
by some of the subjects, certain of the agents have a direct
action on the adrenergic nervous system, e.g. MeIleril and
Trasicor. However, we consider that the basic psychologi-
cal difference which became manifest between the two
groups is not thereby vitiated, since subjects in both groups
were involved, and also since subjects acted as their own
controls.
Although the original emphasis in desensitization thera-
py was on relaxation by reduction of muscular tension,
recent work has begun to question the precise psycho-
physiological axis involved.·,13 Gelder· has measured fore-
arm EMG during 6 desensitization sessions, and concludes:
'There was thus no evidence that "relaxation" induced any
change in muscle tension . . . relaxation procedures are
probably important in lowering general arousal levels ...
muscle relaxation per se does not appear essential'. It was
precisely such a lowering of 'general arousal levels' that
was produced by methoxyflurane.
Our resuIts show that:
1. During RI and NI there was no correlation between
any physiological and psychological measure. -
2. During none of the stimulation sequences was there
any significant separation of physiological measures be-
tween the 'drug' and 'no-drug' groups.
3. We did observe a diminution in heart rate, galvanic
skin response and EMG response among some members of
both groups, which may be ascribed to the effect of habitu-
ation; but, neither the rate nor the degree of habituation
varied significantly between the two groups.
4. Since this occurred without significant distinction in
both the 'relaxed' and 'control' groups, it cannot be held
to account for the significant separation which was noted
in our psychological findings.
CONCLUSIONS
The subjects in the 'relaxed' group found the situation less
stressful both during the use of methoxyflurane and on the
following day. Learning by desensitization had therefore
occurred. This was not reflected in any concomitant auto-
nomic change.
We therefore suggest that a cognitive and affective in-
fluence is at work; that, in other words, the stressful situa-
tion has been given a different psychological significance
and emotional value to the patient. For emotion to be
experienced there must be both a physical and a psycho-
logical correlate present," yet behavourists have tended to
overlook the importance of cognitive and affective elements
in this duality.
Therefore the technique and theory of therapy by recip-
rocal inhibition may be subsumed under the general classi-
fication of 'insight' psychotherapy.
This work was carried out under the aegis of the Department
of Psychiatry, Medical School, University of the Witwatersrand,
Johannesburg, and was conducted at the National Institute for
Personnel Research of the South African Council for Scienti-
fic and Industrial Research, Johannesburg. We should like to
thank: Professor L. A. Hurst, Professor of Psychiatry; the
Superintendent of Tara Hospital; Dr L. Isserow; and Mr G.
K. Nelson, Deputy Director of NIPR, for the facilities and
other assistance extended to us; and Mr R. D. Griesel for
help in designing, conducting and evaluating this investigation.
We are also indebted to Messrs Abbott Laboratories for the
supplies of Penthrane.
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